Atorvastatin intra-subject Variability [Study As­sess­ment]

posted by nobody – 2017-09-27 10:11  – Posting: # 17832
Views: 3,837

» Chance?
Maybe, but...

» Better assay?
No

» Design differences?
How?

» Lesser within-batch variability (-ies) than in the studies you compare to?
Variability has been attributed to various physiological sources, including e.g. liver function, transporter status:

https://www.ncbi.nlm.nih.gov/pubmed/22167570
https://www.ncbi.nlm.nih.gov/pubmed/21548957
https://www.ncbi.nlm.nih.gov/pubmed/20818835

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
20,793 posts in 4,353 threads, 1,445 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: 00:38 CEST (Europe/Vienna)

In God we trust;
all others must bring data.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5